Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ReTuBi

Financiado

Cerrado

Towards outstanding research and training in tumour biology at IMM

Cancer is a major societal health issue in Europe. In 2012, cancer accounted for around 1.3 million deaths and an estimated economic impact of around € 126 billion in the European Union (EU). The Instituto de Medicina Molecular (I... ver más

31/12/2018

iMM

1,000K€

Presupuesto del proyecto: 1,000K€

Líder del proyecto

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 3 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-12-31

H2020-TWINN-2015: Twinning

I+D

Cerrada hace 9 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

3 Participantes

iMM

788.73K€ | Lider

GERMAN CANCER RESEARCH CENTE...

105.63K€ | Participante

INSTITUT CURIE FONDATION

105.63K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PROSTarget PROSTarget Understanding the aggressive nature and key mole... 165K€ Cerrado

TRANSCAN ERA NET on Translational Cancer Research 2M€ Cerrado

EUROCANPLATFORM A European Platform for Translational Cancer Research 16M€ Cerrado

TUMORGAN Exploring the tumor as a communicating organ 1M€ Cerrado

MEL-PLEX Exploiting MELanoma disease comPLEXity to address European r... 4M€ Cerrado

TUMIC An integrated concept of tumor metastasis implications for... 4M€ Cerrado

Duración del proyecto: 36 meses Fecha Inicio: 2015-12-02
Fecha Fin: 2018-12-31

Líder del proyecto

INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANT... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1,000K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is a major societal health issue in Europe. In 2012, cancer accounted for around 1.3 million deaths and an estimated economic impact of around € 126 billion in the European Union (EU). The Instituto de Medicina Molecular (IMM) aims to fight this destructive disease by reinforcing its capacity for outstanding pre-clinical and translation research, and by creating a dynamic cluster of excellence within the Lisbon region in the field of cancer research. Towards this goal, IMM is building up a network for outstanding research and innovation with two leading research institutes, the Institut Curie (the largest European cancer research centre), and the DFKZ - Deutsches Krebsforschungszentrum (the largest cancer research institute in Germany), the ReTuBi consortium. ReTuBi targets 4 specific scientific areas: Cancer Stem Cells; Cancer Signalling; Cancer Invasion and Metastasis; and Tumour Angiogenesis. ReTuBi is designed to stimulate the establishment of novel and long-lasting interactions between groups at IMM, Institut Curie and DFKZ. The dynamic and intensive research framework is focused on promoting the exchange of know-how in research excellence and cutting-edge technologies to tackle current and future challenges in tumour biology. Through this initiative, ReTuBi expects an increase of 30% in multiple indicators until 2020, including the number of citations per publication; h-index of IMM researchers; percentage of publications in top 10% impact journals; number of filed patents; and number of international collaborative projects. ReTuBi will also have an impact in the entire IMM community and Lisbon area, through organisation of open scientific meetings, summer schools, and workshops. ReTuBi extensive dynamic network of interactions will provide a channel of knowledge transfer to potentiate already existent scientific and innovative capacity within IMM, promoting an overall increase in competitiveness of Portugal and EU.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores